Jove
Visualize
Contact Us

Related Experiment Videos

Lymphadenopathy.

T M Habermann1, D P Steensma

  • 1Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Mayo Clinic Proceedings
|July 25, 2000
PubMed
Summary
This summary is machine-generated.

Enlarged lymph nodes, or lymphadenopathy, can signal various conditions, including early signs of malignant disorders. This review guides diagnosis and management of abnormal lymph nodes across different patient groups and body regions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS.

Leukemia·2020
Same author

Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials.

Blood cancer journal·2018
Same author

Reply to the letter to the editor 'Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting' by van der Galiën et al.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Vitamin D insufficiency is associated with an increased risk of early clinical failure in follicular lymphoma.

Blood cancer journal·2017
Same author

Therapy-related myelodysplastic syndromes-specific risk stratification: are we putting the cart before the horse?

Leukemia·2017
Same journal

Thyroid Dysfunction and the Risk of Clinically Relevant Depression: A Longitudinal Cohort Study.

Mayo Clinic proceedings·2026
Same journal

37-Year-Old Woman With Jaundice.

Mayo Clinic proceedings·2026
Same journal

34-Year-Old Woman With An Unidentified Overdose.

Mayo Clinic proceedings·2026
Same journal

Use of Bronchoscopic Cryobiopsy in Evaluating Interstitial Lung Disease: Radiologic Predictors of Diagnostic Yield and Safety.

Mayo Clinic proceedings·2026
Same journal

Advancing Pulmonary Fibrosis Care: Integrating Genomic Insights Into Clinical Practice.

Mayo Clinic proceedings·2026
Same journal

RAAS Inhibition in the ICU: Stop, Continue, or Restart?

Mayo Clinic proceedings·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Internal Medicine
  • Oncology
  • Pathology

Background:

  • Lymphadenopathy, characterized by enlarged lymph nodes, affects all age groups and can be symptomatic or asymptomatic.
  • It is associated with a wide spectrum of disorders, ranging from benign to malignant conditions.
  • Abnormal lymph nodes may be detected through self-examination, clinical assessment, or radiological imaging.

Purpose of the Study:

  • To provide a comprehensive overview of lymphadenopathy.
  • To guide the selection of patients for lymph node biopsy.
  • To identify the most diagnostically valuable lymph node regions and outline a systematic approach to differential diagnosis.

Main Methods:

  • Review of existing literature and clinical guidelines on lymphadenopathy.

Related Experiment Videos

  • Analysis of diagnostic yield based on lymph node location.
  • Compilation of a broad differential diagnosis for enlarged lymph nodes.

    • Main Results:

    • Lymphadenopathy can be the initial manifestation of curable malignant diseases.
    • Specific lymph node regions offer higher diagnostic potential.
    • A structured, region-specific approach aids in narrowing the differential diagnosis.

    Conclusions:

    • Effective management of lymphadenopathy requires understanding its diverse causes and diagnostic pathways.
    • Timely biopsy and appropriate diagnostic workup are crucial, especially when malignancy is suspected.
    • This review offers a framework for evaluating patients with enlarged lymph nodes, facilitating accurate diagnosis and treatment planning.